Kringle Pharma, Inc. (TYO:4884)

Kringle Pharma Revenue

Kringle Pharma had revenue of 17.43M JPY in the quarter ending March 31, 2026, with 3.51% growth. This brings the company's revenue in the last twelve months to 73.00M, up 1.39% year-over-year. In the fiscal year ending September 30, 2025, Kringle Pharma had annual revenue of 72.00M, down -10.00%.

• Revenue (ttm): 73.00M
• Revenue Growth: +1.39%
• P/S Ratio: 38.19
• Revenue / Employee: 4.29M
• Employees: 17
• Market Cap: 2.79B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2025	72.00M	-8.00M	-10.00%
Sep 30, 2024	80.00M	11.00M	15.94%
Sep 30, 2023	69.00M	-322.00M	-82.35%
Sep 30, 2022	391.00M	102.00M	35.29%
Sep 30, 2021	289.00M	-178.00M	-38.12%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 2, 2026

Data Sources Report a data error